Downregulation of FBXO43 has been shown to significantly suppress the malignant phenotypes of breast cancer cells, which may be dependent on proliferating cell nuclear antigen (PCNA) degradation and inactivation [5]. The gene discussed is PCNA; the disease is breast cancer.